Alterations of ocular surface microbiome in glaucoma and its association with dry eye
-
Quality control
- Retracted paper
- Contamination issues suspected
- Batch effect issues suspected
- Uncontrolled confounding suspected
- Results are suspect (various reasons)
- Tags applied
Experiment 1
Subjects
- Location of subjects
- Tunisia
- Host species Species from which microbiome was sampled. Contact us to have more species added.
- Homo sapiens
- Body site Anatomical site where microbial samples were extracted from according to the Uber Anatomy Ontology
- Conjunctiva Conjunctiva,conjunctiva,Conjunctivae,Conjunctivas,Tunica conjunctiva,Wall of conjunctival sac
- Condition The experimental condition / phenotype studied according to the Experimental Factor Ontology
- Glaucoma glaucoma,glaucoma (disease),Glaucoma (disorder),Glaucoma associated with other ocular disorders,Glaucoma associated with other ocular disorders (disorder),Glaucoma associated with other ocular disorders NOS,Glaucoma associated with other ocular disorders NOS (disorder),GLAUCOMA NEC,Glaucoma NOS,Glaucoma NOS (disorder),Glaucoma, NOS,Glaucomas,Other specified forms of glaucoma,Other specified forms of glaucoma (disorder),Other specified glaucoma,Other specified glaucoma NOS,Other specified glaucoma NOS (disorder),Unspecified glaucoma,Glaucoma
- Group 0 name Corresponds to the control (unexposed) group for case-control studies
- HC (Healthy Controls)
- Group 1 name Corresponds to the case (exposed) group for case-control studies
- G-only (Glaucomatous patients without dry eye syndrome)
- Group 1 definition Diagnostic criteria applied to define the specific condition / phenotype represented in the case (exposed) group
- Glaucomatous patients without dry eye syndrome
- Group 0 sample size Number of subjects in the control (unexposed) group
- 60
- Group 1 sample size Number of subjects in the case (exposed) group
- 24
- Antibiotics exclusion Number of days without antibiotics usage (if applicable) and other antibiotics-related criteria used to exclude participants (if any)
- 1 month
Lab analysis
- Sequencing type
- 16S
- 16S variable region One or more hypervariable region(s) of the bacterial 16S gene
- V1-V3
- Sequencing platform Manufacturer and experimental platform used for quantifying microbial abundance
- Illumina
Statistical Analysis
- Data transformation Data transformation applied to microbial abundance measurements prior to differential abundance testing (if any).
- raw counts
- Statistical test
- DESeq2
- Significance threshold p-value or FDR threshold used for differential abundance testing (if any)
- 0.05
- MHT correction Have statistical tests be corrected for multiple hypothesis testing (MHT)?
- Yes
- Matched on Factors on which subjects have been matched on in a case-control study
- age
Alpha Diversity
- Shannon Estimator of species richness and species evenness: more weight on species richness
- unchanged
- Chao1 Abundance-based estimator of species richness
- unchanged
- Simpson Estimator of species richness and species evenness: more weight on species evenness
- unchanged
Signature 1
Source: Figure 2A, Supplementary table 2
Description: Most differentially abundant genera and phyla between groups, identified by DESeq2.
Abundance in Group 1: increased abundance in G-only (Glaucomatous patients without dry eye syndrome)
Revision editor(s): Anne-mariesharp
Experiment 2
Subjects
- Group 1 name Corresponds to the case (exposed) group for case-control studies
- G-DED (Glaucomatous patients with dry eye syndrome)
- Group 1 definition Diagnostic criteria applied to define the specific condition / phenotype represented in the case (exposed) group
- Glaucomatous patients with dry eye syndrome
- Group 1 sample size Number of subjects in the case (exposed) group
- 30
Lab analysis
Statistical Analysis
Alpha Diversity
- Shannon Estimator of species richness and species evenness: more weight on species richness
- unchanged
- Chao1 Abundance-based estimator of species richness
- unchanged
- Simpson Estimator of species richness and species evenness: more weight on species evenness
- increased
Signature 1
Source: Figure 2A, Supplementary table 2
Description: Most differentially abundant genera and phyla between groups, identified by DESeq2.
Abundance in Group 1: increased abundance in G-DED (Glaucomatous patients with dry eye syndrome)
Revision editor(s): Anne-mariesharp
Signature 2
Source: Supplementary table 2
Description: Most differentially abundant genera between groups, identified by DESeq2.
Abundance in Group 1: decreased abundance in G-DED (Glaucomatous patients with dry eye syndrome)
NCBI | Quality Control | Links |
---|---|---|
Enterobacter |
Revision editor(s): Anne-mariesharp
Experiment 3
Subjects
- Condition The experimental condition / phenotype studied according to the Experimental Factor Ontology
- Dry eye syndrome dry eye,Dry Eye Syndrome,dry eye syndrome,Dry Eye Syndromes,dry eye(s),eye(s), dry,KCS,Keraconjunctivitis sicca,Keratoconjunctivitis Sicca,Keratoconjunctivitis sicca,keratoconjunctivitis sicca,Keratoconjunctivitis sicca (disorder),sicca, keratoconjunctivitis,Tear film insufficiency,tear film insufficiency,Dry eye syndrome
- Group 1 name Corresponds to the case (exposed) group for case-control studies
- DED-only (Dry eye syndrome patients without glaucoma)
- Group 1 definition Diagnostic criteria applied to define the specific condition / phenotype represented in the case (exposed) group
- Dry eye syndrome (DED) patients without glaucoma
- Group 1 sample size Number of subjects in the case (exposed) group
- 25
Lab analysis
Statistical Analysis
Alpha Diversity
- Shannon Estimator of species richness and species evenness: more weight on species richness
- unchanged
- Chao1 Abundance-based estimator of species richness
- unchanged
- Simpson Estimator of species richness and species evenness: more weight on species evenness
- unchanged
Signature 1
Source: Supplementary table 2
Description: Most differentially abundant genera between groups, identified by DESeq2.
Abundance in Group 1: increased abundance in DED-only (Dry eye syndrome patients without glaucoma)
NCBI | Quality Control | Links |
---|---|---|
Acinetobacter | ||
Bradyrhizobium | ||
Corynebacterium | ||
Cutibacterium | ||
Enterobacter | ||
Haemophilus | ||
Pseudomonas | ||
Staphylococcus | ||
Streptococcus | ||
Veillonella | ||
Escherichia/Shigella sp. |
Revision editor(s): Anne-mariesharp
Experiment 4
Subjects
- Group 0 name Corresponds to the control (unexposed) group for case-control studies
- G-only (Glaucomatous patients without dry eye syndrome)
- Group 1 name Corresponds to the case (exposed) group for case-control studies
- G-DED (Glaucomatous patients with dry eye syndrome)
- Group 1 definition Diagnostic criteria applied to define the specific condition / phenotype represented in the case (exposed) group
- Glaucomatous patients with dry eye syndrome
- Group 0 sample size Number of subjects in the control (unexposed) group
- 24
- Group 1 sample size Number of subjects in the case (exposed) group
- 30
Lab analysis
Statistical Analysis
- Matched on Factors on which subjects have been matched on in a case-control study
- Not specified
Alpha Diversity
- Shannon Estimator of species richness and species evenness: more weight on species richness
- unchanged
- Chao1 Abundance-based estimator of species richness
- unchanged
- Simpson Estimator of species richness and species evenness: more weight on species evenness
- unchanged
Signature 1
Source: Figure 2A, Supplementary table 2
Description: Most differentially abundant genera and phyla between groups, identified by DESeq2.
Abundance in Group 1: increased abundance in G-DED (Glaucomatous patients with dry eye syndrome)
NCBI | Quality Control | Links |
---|---|---|
Acinetobacter | ||
Bacillota | ||
Haemophilus | ||
Kocuria | ||
Micrococcus | ||
Paracoccus | ||
Pseudomonadota | ||
Rhodobacter | ||
Staphylococcus |
Revision editor(s): Anne-mariesharp
Signature 2
Source: Supplementary table 2
Description: Most differentially abundant genera between groups, identified by DESeq2.
Abundance in Group 1: decreased abundance in G-DED (Glaucomatous patients with dry eye syndrome)
NCBI | Quality Control | Links |
---|---|---|
Enterobacter | ||
Proteus |
Revision editor(s): Anne-mariesharp
Experiment 5
Subjects
- Condition The experimental condition / phenotype studied according to the Experimental Factor Ontology
- Glaucoma glaucoma,glaucoma (disease),Glaucoma (disorder),Glaucoma associated with other ocular disorders,Glaucoma associated with other ocular disorders (disorder),Glaucoma associated with other ocular disorders NOS,Glaucoma associated with other ocular disorders NOS (disorder),GLAUCOMA NEC,Glaucoma NOS,Glaucoma NOS (disorder),Glaucoma, NOS,Glaucomas,Other specified forms of glaucoma,Other specified forms of glaucoma (disorder),Other specified glaucoma,Other specified glaucoma NOS,Other specified glaucoma NOS (disorder),Unspecified glaucoma,Glaucoma
- Group 0 name Corresponds to the control (unexposed) group for case-control studies
- DED-only (Dry eye syndrome patients without glaucoma)
- Group 1 name Corresponds to the case (exposed) group for case-control studies
- G-only (Glaucomatous patients without dry eye syndrome)
- Group 1 definition Diagnostic criteria applied to define the specific condition / phenotype represented in the case (exposed) group
- Glaucomatous patients without dry eye syndrome
- Group 0 sample size Number of subjects in the control (unexposed) group
- 25
- Group 1 sample size Number of subjects in the case (exposed) group
- 24
Lab analysis
Statistical Analysis
Alpha Diversity
- Shannon Estimator of species richness and species evenness: more weight on species richness
- unchanged
- Chao1 Abundance-based estimator of species richness
- unchanged
- Simpson Estimator of species richness and species evenness: more weight on species evenness
- unchanged
Signature 1
Source: Figure 2A, Supplementary table 2
Description: Most differentially abundant genera and phyla between groups, identified by DESeq2.
Abundance in Group 1: increased abundance in G-only (Glaucomatous patients without dry eye syndrome)
NCBI | Quality Control | Links |
---|---|---|
Enterobacter | ||
Pseudomonadota |
Revision editor(s): Anne-mariesharp
Experiment 6
Subjects
- Group 1 name Corresponds to the case (exposed) group for case-control studies
- G-DED (Glaucomatous patients with dry eye syndrome)
- Group 1 definition Diagnostic criteria applied to define the specific condition / phenotype represented in the case (exposed) group
- Glaucomatous patients with dry eye syndrome
- Group 1 sample size Number of subjects in the case (exposed) group
- 30
Lab analysis
Statistical Analysis
Alpha Diversity
- Shannon Estimator of species richness and species evenness: more weight on species richness
- unchanged
- Chao1 Abundance-based estimator of species richness
- unchanged
- Simpson Estimator of species richness and species evenness: more weight on species evenness
- unchanged
Signature 1
Source: Figure 2A
Description: Most differentially abundant phyla between groups, identified by DESeq2.
Abundance in Group 1: increased abundance in G-DED (Glaucomatous patients with dry eye syndrome)
NCBI | Quality Control | Links |
---|---|---|
Bacillota | ||
Pseudomonadota | ||
Bacteroidota |
Revision editor(s): Anne-mariesharp